JXSS2200004 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.1) | Import Drug Application | 2022-01-26 | | | | | view |
JXSL2300208 | 注射用重组单链人凝血因子VIII | | Lyophilized | Biological Products(3.1) | Import Drug Application | 2023-11-28 | | | | | view |
JYSB1900085 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2019-04-24 | | | Certificate Issued | 2019-10-30 | view |
JYSB2101027 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2021-05-12 | | Bayer Healthcare LLC | | | view |
CYSB2200148 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-06-08 | | Shanghai RAAS Blood Products Co Ltd | | | view |
JYSB1800176 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2018-08-17 | | | Filed | 2018-08-23 | view |
JXSL1600041 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2016-07-11 | | Bayer Healthcare LLC | Certificate Issued | 2018-07-27 | view |
JYSB2000430 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2020-09-03 | | | Certificate Issued | 2020-10-27 | view |
JYSB2100025 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2021-01-22 | | | In Review | 2021-01-21 | view |
CYSB2200143 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-06-08 | | Shanghai RAAS Blood Products Co Ltd | | | view |
JYSB1500135 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2015-05-19 | | | Certificate Issued | 2017-03-27 | view |
JTS2400104 | 注射用培重组人凝血因子VIII | | | Biological Products | Disposable Import Drug Application | 2024-09-25 | | | | | view |
JXSS1000006 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2010-06-21 | | | Certificate Issued | 2012-05-10 | view |
JYSB2200143 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-08-08 | | Bayer Healthcare LLC | | | view |
CXSL2400210 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.4) | New Drug Application | 2024-04-03 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
JXSL0900029 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2009-05-11 | | Wyeth Pharmaceuticals Inc | Certificate Issued | 2010-05-27 | view |
JYSZ2200030 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | License Renew | 2022-06-29 | | | | | view |
JYSB2300034 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2023-02-23 | | Bayer Healthcare LLC | | | view |
JYSB1800190 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2018-09-10 | | | Certificate Issued | 2019-02-02 | view |
JYSB1800056 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2018-03-28 | | | Filed | 2018-04-13 | view |